- Home
- HOLX
HOLX
Hologic Inc.
as 10-07-2025 3:29pm EST
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
| Founded: | 1985 | Country: | United States |
| Employees: | N/A | City: | MARLBOROUGH |
| Market Cap: | 15.0B | IPO Year: | 1990 |
| Target Price: | $78.92 | AVG Volume (30 days): | 2.3M |
| Analyst Decision: | Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.41 | EPS Growth: | -17.18 |
| 52 Week Low/High: | $51.90 - $84.39 | Next Earning Date: | 11-03-2025 |
| Revenue: | $4,038,900,000 | Revenue Growth: | 1.29% |
| Revenue Growth (this year): | 3.37% | Revenue Growth (next year): | 4.51% |
Stock Insider Trading Activity of Hologic Inc. (HOLX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| MACMILLAN STEPHEN P | HOLX | Chairman, President and CEO | Sep 22 '25 | Sell | $66.83 | 138,358 | $9,266,117.92 | 1,350,742 |
Latest Hologic Inc. News
HOLX Breaking Stock News: Dive into HOLX Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
How to Play HOLX Stock This Breast Cancer Awareness Month?
Zacks
5 days ago
HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests
Zacks
5 days ago
Why Hologic (HOLX) Outpaced the Stock Market Today
Business Wire
5 days ago
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025
Simply Wall St.
5 days ago
Hologic (HOLX): Assessing Valuation Following Upbeat Earnings, Guidance Boost, and New Partnership Moves
Zacks
6 days ago
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
MT Newswires
6 days ago
Hologic Says Gastroenteritis Tests Get US FDA Clearance, CE Mark
Business Wire
6 days ago
Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis
Compare HOLX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HOLX Hologic Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.